Acentra Health Enhances AI Capabilities Through Partnership with Socially Determined | CG Stock News

Article's Main Image

Acentra Health has announced a strategic collaboration with Socially Determined to enhance its data analytics and AI infrastructure. This partnership aims to revolutionize how state healthcare agencies predict and target interventions, focusing on improving health outcomes while managing costs efficiently.

By integrating Socially Determined’s advanced social risk data and specialized risk scores, Acentra Health will gain deeper insights from Medicaid claims data. This access is expected to significantly bolster Acentra Health's capabilities in processing real-time intelligence and analysis, thereby fostering improved population health management strategies.

The collaboration leverages a combination of extensive data access, computing power, and AI analytics, promising a more precise and cost-effective approach to healthcare interventions. By tapping into these resources, Acentra Health aims to create a repeatable and scalable process for delivering enhanced health solutions to communities nationwide.

Wall Street Analysts Forecast

1915403601522618368.png

Based on the one-year price targets offered by 16 analysts, the average target price for The Carlyle Group Inc (CG, Financial) is $49.75 with a high estimate of $83.00 and a low estimate of $37.00. The average target implies an upside of 35.97% from the current price of $36.59. More detailed estimate data can be found on the The Carlyle Group Inc (CG) Forecast page.

Based on the consensus recommendation from 18 brokerage firms, The Carlyle Group Inc's (CG, Financial) average brokerage recommendation is currently 2.7, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.

Based on GuruFocus estimates, the estimated GF Value for The Carlyle Group Inc (CG, Financial) in one year is $51.39, suggesting a upside of 40.45% from the current price of $36.59. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the The Carlyle Group Inc (CG) Summary page.

CG Key Business Developments

Release Date: February 11, 2025

  • Fee-Related Earnings (FRE): Over $1.1 billion, a near 30% increase over 2023.
  • FRE Margin: Expanded to 46%, a 900-basis point year-over-year increase.
  • Inflows: Exceeded $40 billion for the year, totaling more than $100 billion over the last two years.
  • Capital Returned to Shareholders: More than $1 billion.
  • Global Credit Revenue Growth: Increased by 22% in 2024.
  • Assets Under Management (AUM) in Global Credit: $190 billion.
  • Global Investment Solutions Fee Revenue Growth: Increased by 44% compared to the prior year.
  • Global Wealth Business Inflows: Record inflows of $4.5 billion.
  • Global Wealth AUM Growth: Increased by 65% to over $9 billion.
  • US Buyout Funds Performance: Appreciated 15% and 21%, respectively, in 2024.
  • Real Estate AUM Growth: Increased more than 80% over the past four years.
  • Distributable Earnings (DE): $1.5 billion for the year, or $3.66 per share.
  • Transaction Fees: More than doubled to $164 million.
  • Pending Fee-Earning AUM: $23 billion, up nearly 50% year over year.
  • FRE Cash Compensation Ratio: Improved to 36% in 2024, down from 45% in the prior year.
  • Fundraising: Strong inflows of more than $14 billion in the fourth quarter and nearly $41 billion for the year.
  • Dry Powder: $84 billion available for investment.
  • Corporate Private Equity Realized Proceeds: Nearly doubled from the prior year.
  • Proceeds Distributed to US Buyout Investors: $5.3 billion throughout the year.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

  • The Carlyle Group Inc (CG, Financial) achieved a record performance in 2024, generating over $1.1 billion in fee-related earnings, marking a near 30% increase over 2023.
  • The company expanded its fee-related earnings (FRE) margin to 46%, a 900-basis point year-over-year increase.
  • Inflows exceeded $40 billion in 2024, contributing to more than $100 billion of inflows over the last two years.
  • The Global Credit segment remained the fastest-growing area, with revenues increasing 22% in 2024 and assets under management reaching $190 billion.
  • The Carlyle Group Inc (CG) returned more than $1 billion in capital to shareholders and implemented a $1.4 billion share repurchase authorization, reflecting confidence in the company's undervalued share price.

Negative Points

  • Global Private Equity management fees declined by 7% in 2024, with expectations of a continued, albeit more modest, decline in 2025.
  • The CLO business within the Global Credit segment faced market headwinds, impacting management fees.
  • The fee-paying assets under management experienced a $6 billion mark-to-market decline due to credit market activity, although it was described as having a minor economic impact.
  • The company anticipates a modest 6% growth in fee-related earnings for 2025, with potential upside dependent on market conditions.
  • Realization activity levels are expected to increase in 2025, but the 6% FRE growth forecast does not assume a substantial pickup in realizations.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.